This study revealed that NELFE functions as an oncogene in GC and a new oncogenic NELFE/β-catenin/CSNK2B signaling axis was identified, which may help to develop new diagnosis and treatment strategies against GC (Fig. 7). The gene discussed is NELFE; the disease is gastric cancer.